Now a research team, led by UCLA’s Anusha Kalbasi, MD, in collaboration with scientists from Stanford and the University of Pennsylvania, has shown that a synthetic IL-9 receptor allows those cancer-fighting T cells to do their work without the need for chemo or radiation. T cells engineered with the synthetic IL-9 receptor, designed in the laboratory of Christopher Garcia, PhD, at Stanford, were potent against tumors in mice, as published Wednesday in Nature.

“When T cells are signaling through the synthetic IL-9 receptor, they gain new functions that help them not only outcompete the existing immune system but also kill cancer cells more efficiently,” Kalbasi said. “I have a patient right now struggling through toxic chemotherapy just to wipe out his existing immune system so T cell therapy can have a fighting chance. But with this technology you might give T cell therapy without having to wipe out the immune system beforehand.”

Kalbasi, a researcher at the UCLA Jonsson Comprehensive Cancer Center and an assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA, began the work while under the mentorship of Antoni Ribas, MD, PhD, a senior investigator on the study. The study was also led by Mikko Siurala, PhD, from the laboratory of Carl June, MD, at Penn, and Leon L. Su, PhD, of the Garcia Lab at Stanford.

“This finding opens a door for us to be able to give T cells a lot like we give a blood transfusion,” Ribas said.

Ribas and Garcia collaborated on a paper published in 2018 that focused on the concept that a synthetic version of interleukin-2 (IL-2), a critical T cell growth cytokine, could be used to stimulate T cells engineered with a matching synthetic receptor for the synthetic IL-2. With this system, T cells can be manipulated even after they have been given to a patient, by treating the patient with the synthetic cytokine (which has no effect on other cells in the body). Intrigued by that work, Kalbasi and colleagues were interested in testing modified versions of the synthetic receptor that transmit other cytokine signals from the common-gamma chain family: IL-4, -7, -9 and -21.

“It was clear early on that, among the synthetic common-gamma chain signals, the IL-9 signal was worth investigating,” Kalbasi said, adding that unlike other common-gamma chain cytokines, IL-9 signaling is not typically active in naturally occurring T cells. The synthetic IL-9 signal made T cells take on a unique mix of both stem-cell and killer-like qualities that made them more robust in fighting tumors. “In one of our cancer models, we cured over half the mice that were treated with the synthetic IL-9 receptor T cells.”

Kalbasi said the therapy proved to be effective in multiple systems. They targeted two types of hard-to-treat cancer models in mice — pancreatic cancer and melanoma — and used T cells targeted to cancer cells through the natural T cell receptor or a chimeric antigen receptor (CAR). “The therapy also worked whether we gave the cytokine to the whole mouse or directly to the tumor. In all cases, T cells engineered with synthetic IL-9 receptor signaling were superior and helped us cure some tumors in mice when we couldn’t do it otherwise.”

Setting out to investigate how social isolation and loneliness were related to later dementia, researchers at the University of Warwick, University of Cambridge and Fudan University used neuroimaging data from more than 30,000 participants in the UK Biobank data set. Socially isolated individuals were found to have lower gray matter volumes of brain regions involved in memory and learning.

The results of the study are published online today (June 8, 2022) in Neurology, the medical journal of the American Academy of Neurology, in a paper entitled “Associations of social isolation and loneliness with later dementia” by Shen, Rolls, Cheng, Kang, Dong, Xie, Zhao, Sahakian and Feng.

Based on data from the UK Biobank, an extremely large longitudinal cohort, the researchers used modelling techniques to investigate the relative associations of social isolation and loneliness with incident all-cause dementia. After adjusting for various risk factors (including socio-economic factors, chronic illness, lifestyle, depression and APOE genotype), socially isolated individuals were shown to have a 26% increased likelihood of developing dementia.

Loneliness was also associated with later dementia, but that association was not significant after adjusting for depression, which explained 75% of the relationship between loneliness and dementia. Therefore, relative to the subjective feeling of loneliness, objective social isolation is an independent risk factor for later dementia. Further subgroup analysis showed that the effect was prominent in those over 60 years old.

Professor Edmund Rolls, neuroscientist from the University of Warwick Department of Computer Science, said: “There is a difference between social isolation, which is an objective state of low social connections, and loneliness, which is subjectively perceived social isolation.

“Both have risks to health but, using the extensive multi-modal data set from the UK Biobank, and working in a multidisciplinary way linking computational sciences and neuroscience, we have been able to show that it is social isolation, rather than the feeling of loneliness, which is an independent risk factor for later dementia. This means it can be used as a predictor or biomarker for dementia in the UK.

“With the growing prevalence of social isolation and loneliness over the past decades, this has been a serious yet underappreciated public health problem. Now, in the shadow of the COVID-19 pandemic there are implications for social relationship interventions and care — particularly in the older population.”

Professor Jianfeng Feng, from the University of Warwick Department of Computer Science, said: “We highlight the importance of an environmental method of reducing risk of dementia in older adults through ensuring that they are not socially isolated. During any future pandemic lockdowns, it is important that individuals, especially older adults, do not experience social isolation.”

Professor Barbara J Sahakian, of the University of Cambridge Department of Psychiatry, said: “Now that we know the risk to brain health and dementia of social isolation, it is important that the government and communities take action to ensure that older individuals have communication and interactions with others on a regular basis.”

“Although optimism itself may be affected by social structural factors, such as race and ethnicity, our research suggests that the benefits of optimism may hold across diverse groups,” said Hayami Koga, a PhD candidate in the Department of Social and Behavioral Sciences at Harvard Chan School and lead author of the study. “A lot of previous work has focused on deficits or risk factors that increase the risks for diseases and premature death. Our findings suggest that there’s value to focusing on positive psychological factors, like optimism, as possible new ways of promoting longevity and healthy aging across diverse groups.”

The study will be published online on June 8, 2022, in the Journal of the American Geriatrics Society.

In a previous study, the research group determined that optimism was linked to a longer lifespan and exceptional longevity, which was defined as living beyond 85 years of age. Because they had looked at mostly white populations in that previous study, Koga and her colleagues broadened the participant pool in the current study to include women from across racial and ethnic groups. According to Koga, including diverse populations in research is important to public health because these groups have higher mortality rates than white populations, and there is limited research about them to help inform health policy decisions.

For this study, the researchers analyzed data and survey responses from 159,255 participants in the Women’s Health Initiative, which included postmenopausal women in the U.S. The women enrolled at ages 50-79 from 1993 to 1998 and were followed for up to 26 years.

Of the participants, the 25% who were the most optimistic were likely to have a 5.4% longer lifespan and a 10% greater likelihood of living beyond 90 years than the 25% who were the least optimistic. The researchers also found no interaction between optimism and any categories of race and ethnicity, and these trends held true after taking into account demographics, chronic conditions, and depression. Lifestyle factors, such as regular exercise and healthy eating, accounted for less than a quarter of the optimism-lifespan association, indicating that other factors may be at play.

Koga said that the study’s results could reframe how people view the decisions that affect their health.

“We tend to focus on the negative risk factors that affect our health,” said Koga. “It is also important to think about the positive resources such as optimism that may be beneficial to our health, especially if we see that these benefits are seen across racial and ethnic groups.”

This research was supported by the National Institutes of Health (R01AG053273, K08048221). The Women’s Health Initiative is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health, and the Department of Health and Human Services.

Story Source:

Materials provided by Harvard T.H. Chan School of Public Health. Note: Content may be edited for style and length.

The discovery, reported online June 6, 2022, in Molecular Psychiatry, illuminates the molecular details of the brain’s response to alcohol withdrawal, and suggests that the immune protein, colony stimulating factor 1 (CSF1), could be a target of future treatments for alcohol use disorder (AUD).

“Alcohol withdrawal activates the stress system in the brain, which contributes to relapse, and in this study, we linked this stress response to CSF1, a neuroimmune mediator, opening up new opportunities for therapeutic intervention,” says study senior author Marisa Roberto, PhD, professor and Schimmel Family Chair in the Department of Molecular Medicine at Scripps Research.

The study’s first author, who performed many of the experiments, is Reesha R. Patel, PhD, a former postdoctoral researcher in the Roberto lab.

Alcohol is by far the most used and abused recreational drug. According to the 2019 National Survey on Drug Use and Health, nine million men and more than five million women in the United States have an alcohol use disorder (AUD), which is defined as an inability to control alcohol use despite its negative impact on the user’s health, social life and/or employment. Drug treatments, talk-therapy and support group-based treatments are available, but relapse is common, mainly due to the limited understanding of the brain-circuit dysfunctions underlying AUD.

Scientists know that relapse-promoting alcohol withdrawal symptoms include rising feelings of anxiety, caused at least in part by the release of stress molecules such as corticotropin-releasing factor (CRF) within the brain. CRF stimulates receptors on neurons in the prefrontal cortex, and in the limbic system, a set of more primitive brain structures that process emotions. If scientists could fully identify and characterize these CRF-sensitive neuronal populations, they could understand better how anxiety occurs during withdrawal and potentially devise effective treatments to block it.

Toward that end, Roberto and her team, in the new study, identified a population of neurons in the medial prefrontal cortex (mPFC) of mice that are sensitive to CRF because they express a CRF receptor called CRF1. The scientists showed that these neurons are involved in altering mood and behavior during alcohol exposure and withdrawal.

The team’s initial experiments revealed that deletion of these CRF-sensitive neurons makes the mice less anxious, suggesting that the neurons normally mediate anxiety-like behaviors.

The researchers subsequently found that these CRF-sensitive mPFC neurons become less excitable — less likely to fire signals to other neurons when stimulated — in alcohol-dependent mice that experience alcohol withdrawal. In contrast, nearby mPFC neurons lacking CRF receptors become more excitable.

“These CRF-sensitive mPFC neurons appear to constitute a unique neuronal population that undergoes profound neuroadaptations with chronic alcohol exposure,” says study co-author Pauravi Gandhi, PhD, a postdoctoral research associate in the Roberto lab.

Intriguingly, the researchers found that alcohol withdrawal, even as it dialed down the excitability of the CRF-sensitive neurons, also induced large increases in CSF1 gene expression within these neurons. CSF1 is an immune protein best known for its role in stimulating stem cells to mature into large white blood cells called macrophages. In the brain, CSF1 is thought to have a similar role in sustaining brain-resident immune cells called microglia. Moreover, prior research in mice has suggested that under conditions of chronic stress, CSF1 production rises in the mPFC, driving microglia to prune connections between neurons, which in turn causes signs of anxiety and depression.

Looking more closely at CSF1’s role in alcohol withdrawal, Roberto and colleagues artificially increased CSF1 production in CRF-sensitive mPFC neurons in mice, and observed that the animals exhibited many of the same neuronal and behavioral changes seen in alcohol withdrawal — suggesting that elevated CSF1 levels in mPFC may be a key driver of alcohol-withdrawal signs and symptoms.

“Targeting CSF1 therefore may be a good strategy for treating AUD, and we’re now eager to test that in our preclinical models,” Patel says.

In a new study, University of Chicago scientists find that holes can also improve technology, including medical devices. Published in Nature Materials, the paper describes an entirely new way to make a solar cell: by etching holes in the top layer to make it porous. The innovation could form the basis for a less-invasive pacemaker, or similar medical devices. It could be paired with a small light source to reduce the size of the bulky batteries that are currently implanted along with today’s pacemakers.

“We hope this opens many possibilities for further improvements in this field,” said Aleksander Prominski, the first author on the paper.

Light work

Prominski is a member of the lab of University of Chicago chemist Bozhi Tian, which specializes in creating ways to connect biological tissue and artificial materials — such as wires to modulate brain signals and surfaces for medical implants.

One of the areas they’re interested in is making devices that can be powered by light. We’re most familiar with this technology in the form of solar cells, but they can also use any light source, including artificial ones. When operating in the body, such devices are known as photoelectrochemical cells and can be powered from a tiny optical fiber implanted in the body.

Normally, solar cells require two layers, which can be achieved either by combining the silicon with another material such as gold, or by mixing different kinds of atoms into each silicon layer.

But UChicago scientists in the Tian lab found they could create a solar cell out of pure silicon if they made one layer porous, like a sponge.

The resulting soft, flexible cell can be less than five microns across, which is about the size of a single red blood cell. It can then be paired with an optical fiber, which can be made as thin as a strand of human hair — significantly reducing the overall size of an implant, making it more body-friendly and less likely to cause side effects.

The porous cell has multiple advantages over the ways to manufacture traditional solar cells, streamlining the production process while maintaining the efficacy of the final product.

“You can make them in a matter of minutes, and the process doesn’t require high temperatures or toxic gases,” said Prominski.

Added study co-author Jiuyun Shi: “When we measured them, we saw the photocurrent was really high — two orders of magnitude higher than our previous designs.”

Then, to boost the material’s ability to stimulate heart or nerve cells, they treat it with oxygen plasma to oxidize the surface layer. This step is counterintuitive for chemists, because silicon oxide most often works as an insulator, and “you don’t want the photoelectrochemical effect to be impeded by any insulating materials,” said Tian. In this case, however, oxidization actually helps by making the silicon material hydrophilic — attracted to water — which boosts the signal to biological tissues. “Finally, by adding a few-atoms-thick layer of metal oxide, you can further enhance the device properties,” said Pengju Li, another study co-author.

Because all of the components can be made to be biodegradable, the scientists can imagine the technology being used for short-term cardiac procedures. Instead of a second surgery for removal, the parts would degrade naturally after a few months. The innovative approach might also be particularly useful for a procedure called cardiac resynchronization therapy which seeks to correct arrhythmias where the right and left chambers of the heart do not beat in time, because the devices could be placed in multiple areas of the heart to improve coverage.

Prominski is also excited about possible applications for nerve stimulation. “You could imagine implanting such devices in people who have chronic nerve degeneration in the wrists or hands, for example, in order to provide pain relief,” he said.

This novel way of making solar cells could also be of interest for sustainable energy or other non-medical applications. Because these solar cells are designed to work best in a liquid environment, UChicago scientists think they could be used in applications such as artificial leaves and solar fuels.

Tian’s team is working with cardiac researchers at the University of Chicago Medicine to further develop the technology for eventual use in humans. They are also collaborating with the UChicago Polsky Center for Entrepreneurship and Innovation to commercialize the discovery.

Jiping Yue, Yiliang Lin, Jihun Park, and Menahem Rotenberg were also co-authors on the study.

The research used the resources of the Pritzker Nanofabrication Facility at the Pritzker School of Molecular Engineering; the Illinois Innovation Network; the Northwestern University Atomic and Nanoscale Characterization Experimental Center and Northwestern Materials Research Science and Engineering Center; and the University of Chicago Materials Research Science and Engineering Center.

Along some fault lines, which are the boundaries of tectonic plates, a fine-grained gravel is formed as the plates grind against one another. The influence of this gravel on earthquakes has long been the subject of scientific speculation. In a new paper appearing in the journal Nature on June 1, the Caltech researchers show that the fine gravel, known as rock gouge, first halts earthquake propagation, but then triggers the rebirth of earthquakes to generate powerful ruptures.

“Our novel experimental approach has enabled us to look into the earthquake process up close, and to uncover key features of rupture propagation and friction evolution in rock gouge,” says Vito Rubino, research scientist and lead author of the Nature paper. “One of the main findings of our study is that fault sections previously thought to act as barriers against dynamic rupture may in fact host earthquakes, as a result of the activation of co-seismic friction weakening mechanisms.”

In the paper, Rubino and his co-authors Nadia Lapusta, the Lawrence A. Hanson, Jr., Professor of Mechanical Engineering and Geophysics, and Ares Rosakis, Theodore von Kármán Professor of Aeronautics and Mechanical Engineering, show that so-called “stable” or “creeping” faults are not actually immune to major ruptures after all, as previously suspected. Such faults occur when tectonic plates slide past one another slowly, without generating big quakes (for example, the currently creeping section of the San Andreas Fault in central California).

Instead, rock gouge has a complex behavior. It first acts as a barrier to the rupture, absorbing energy and blocking its progress. But, when the plates slide past each other with high enough velocity, the rock gouge interface weakens and dramatically reduces friction between the two plates, causing the re-emergence of the quake. This process is known as “renucleation.”

“Based on the previous rich body of rock-friction experiments, we know that rock gouge can either strengthen with fault slip and act as a barrier, or weaken and promote earthquake rupture,” Lapusta says. “However, these behaviors are typically considered to be separated in space, with weakening and strengthening occurring on different fault locations. Our experiments show how these behaviors can combine on the same fault locations during the same slip event, over the timescales of dynamic rupture, leading to intermittent slip and potentially turning a fault barrier into an earthquake-prone region.”

The Nature study explores the role and reaction of rock gouge, a micrometer-sized granular material, to seismic activity. To simulate the effect of rock gouge on an earthquake’s propagation, the team used Caltech’s so-called seismological wind tunnel, founded by Rosakis and former Caltech Seismological Laboratory director Hiroo Kanamori, John E. and Hazel S. Smits Professor of Geophysics, Emeritus. The facility, in existence since 1999, allows engineers and scientists to study major earthquakes on a miniature scale.

To simulate an earthquake, the team first cut in half a transparent meter-sized block of a type of plastic known as Homalite. The bulk properties of Homalite enable dynamic rupture nucleation within samples as small as tens of centimeters in diameter; studying these effects in rock would require samples that are tens of meters in size.

The researchers then placed the two halves of the Homalite together under high pressure and shear (a situation in which the two halves want to slide against one another in opposite directions), simulating tectonic pressure that slowly builds up along a fault line. Between the pieces, fine-grained quartz powder was embedded as a stand-in for fault gouge. Next, the team put a small wire fuse between the two halves; its location was the “epicenter” of the earthquake they planned to simulate. As the simulated quake progressed, high-speed imaging technology was used to record its evolution, one millionth of a second at a time.

“Back in the late 1990s, when we were designing the ‘seismological wind tunnel,’ we could never have imagined its success in discovering such a rich spectrum of physical phenomena relating to frictional earthquake source processes and that such phenomena could rigorously be scaled to explain natural earthquake behavior occurring at massively different length scale around the globe,” Rosakis says. “This is a testament of the tremendous power of the discipline of mechanics.”

Next, the team plans to study the effects of fluids, which are naturally present in Earth’s crust, on the frictional behavior of rock gouge.

The Nature paper is titled “Intermittent lab earthquakes in dynamically weakening fault gouge.” This research was funded by the National Science Foundation (NSF), the U.S. Geological Survey, the NSF-IUCRC program at Caltech’s Center for Geomechanics and Mitigation of Geohazards (GMG), and the Southern California Earthquake Center (SCEC).